Keynote by Sangita Reddy Joint Managing Director Apollo Hospitals India AI Impact Summit
20 Feb 2026 16:00h - 17:00h
Keynote by Sangita Reddy Joint Managing Director Apollo Hospitals India AI Impact Summit
Summary
The discussion centered on how AI and digital platforms are being used to make Indian health care accessible regardless of a person’s zip code, emphasizing sustainable costs, preventive care, and early detection [1-3]. India’s unique advantage stems from high out-of-pocket spending that drives innovation, a rapidly expanding doctor-nurse workforce, and a talent pool of over 600,000 AI engineers [4]. Apollo Hospitals’ “Apollo 24-7” digital front door lets users purchase medicines, order diagnostics, store health records, and interact with an AI assistant, attracting more than 45 million users and nearly a million daily interactions [12-14].
Their AI ecosystem processes about 3.5 million API calls across five workstreams-including clinical intelligence, doctor-workforce analytics, disease-risk scoring, multimodal imaging, and acute-care pathways-supporting a broad population of 1.4 billion people [19-30]. An early-warning system linked to 2,000 critical-care beds predicts sepsis 24-48 hours before onset, illustrating potential life-saving impact [30-32]. Throughput optimization targets smarter billing, zero waiting times, and automated record capture, with 19 solutions gaining MDSAP approval and nine receiving FDA clearance [35-38]. The EASE framework guides ethical AI adoption, ensuring suitability and explainability for health-care workers [40-43].
Preventive initiatives include AI-embedded ultrasound that detects NAFLD-affecting 40 % of Indian adults-enabling early intervention to avoid liver transplants [47-50]. Risk-scoring tools and an AI pre-diabetes algorithm have already served 450 000 individuals, with aspirations to reach 85 million diabetics [56-62]. Radiology collaborations, such as with Google, enable AI detection of tuberculosis and brain bleeds, facilitating rapid emergency diagnoses [63-66]. The Clinician Co-Pilot AI summarises records, saving 1-1.5 hours of physician time daily, while the Care Console integrates ICU, home, and rural monitoring to reduce staff burnout and improve decision-making [72-77].
Rural outreach extends these solutions via mobile vans for non-communicable disease and cancer screening, tele-ophthalmology, and data sharing with ASHA workers, demonstrating scalability beyond hospital walls and extensive validation efforts [79-82]. The speaker concluded by urging the creation of interconnected health systems that are predictive, preventive, personalized, participatory, and place-agnostic, calling for collaboration across public, private, research, and tech sectors to build a healthier future for all [91-98].
Keypoints
Major discussion points
– A vision of democratized, AI-enabled health care across India – The speaker frames health care as a right not tied to zip code, highlighting India’s large out-of-pocket market, growing medical workforce, and a talent pool of over 600,000 AI engineers that together enable a new collaborative-care paradigm. The launch of “Apollo 24-7,” a digital front-door that lets users order medicines, store records, and interact with AI assistants, already serves 45 million users with about a million daily interactions. This scale is underpinned by a rapidly growing AI platform that has logged roughly 3.5 million API calls. [1-4][12-14][18-20]
– Concrete AI applications that augment clinical practice – The organization has built a multi-layered AI stack: a clinical intelligence engine that gives doctors access to cumulative patient data; a decision-support system analyzing 20 million doctor records; disease-risk scoring for conditions such as cardiac disease, diabetes, and hypertension; multimodal imaging AI that interprets signals faster than any individual; an early-warning sepsis model that predicts onset 24-48 hours in advance for 2,000 ICU beds; and throughput-optimization tools that automate billing and record-population, saving up to 1.5 hours of clinician time per day. [21-24][27-33][34-37][64-66][72-74]
– Ethical governance through the “EASE” framework – To ensure responsible AI use, the speaker introduces the EASE framework, which addresses ethical considerations, suitability of algorithms for specific clinical contexts, and explainability so that health-care workers can understand and trust AI outputs. [40-44]
– Emphasis on preventive care and early disease detection – The talk stresses shifting resources from reactive, high-cost interventions to proactive screening. AI-embedded ultrasound is being used to detect NAFLD (affecting ~40 % of Indian adults) early enough to avoid liver failure; a pre-diabetes algorithm has already been applied to 450,000 individuals with the aim of reaching 85 million diabetics; and collaborations (e.g., with Google) enable AI-driven X-ray analysis for tuberculosis and rapid brain-bleed detection, illustrating how risk scoring and biomarker-based screening can reduce morbidity. [44-49][52-58][61-63]
– Call for a collaborative, integrated health-system ecosystem – The speaker highlights ongoing rural outreach (mobile vans, tele-ophthalmology, ASHA-enabled screening), stresses the importance of rigorous validation to move pilots to mainstream, and envisions a future health system that links public and private sectors, primary and advanced care, research institutions, startups, and even drone logistics. This “flywheel” of data, AI, and partnership is presented as the pathway to a predictive, preventive, personalized, participatory, and place-agnostic health future for every village and city. [80-88][90-98]
Overall purpose / goal
The discussion is a strategic showcase aimed at demonstrating how Apollo Hospitals is leveraging AI, digital platforms, and a vast talent pool to make health care affordable, accessible, and preventive across India. It seeks to inspire confidence in the organization’s technological capabilities, outline concrete AI use cases, present an ethical framework, and rally stakeholders-from researchers to policymakers to industry partners-to collaborate in building an integrated, future-ready health system.
Overall tone
The speaker’s tone is consistently enthusiastic and visionary, punctuated by data-driven confidence when describing platform usage and AI outcomes. As the talk progresses, the tone shifts subtly from showcasing achievements to a more urgent, rally-calling stance, emphasizing the need for broader collaboration, validation, and systemic change to realize the “health systems of the future.” Throughout, the language remains optimistic and forward-looking, with a crescendo of collective responsibility toward the end.
Speakers
– Speaker 1: Dr. Pratap Siredi – Role/Title: Chairman (Apollo Hospitals); Area of expertise: Healthcare leadership, AI‑enabled health services, hospital administration and innovation.
Additional speakers:
– (none)
The speaker opened by asserting that health-care must be a right that does not depend on the postcode where a person is born, and that the system should be built around sustainable costs, preventive care and early detection [1-3]. He argued that India enjoys a unique strategic advantage: a large out-of-pocket spending base that drives innovation while keeping prices low, a rapidly expanding cadre of doctors and nurses, and a talent pool of more than 600 000 AI engineers [4]. This combination, he suggested, creates the conditions for a new collaborative-care paradigm in which technology can be leveraged at national scale [3-4][S4].
To translate that vision into practice, Apollo 24-7 has been launched as a digital front-door that lets users purchase medicines, order diagnostics, store health records and interact with an AI-driven assistant [12-13]. The platform now serves over 45 million registered users and records close to one million daily interactions, evidence that the market is rewarding the digital approach [14]. Its rapid growth is underpinned by an AI platform that has already handled roughly 3.5 million API calls [19-20].
The AI platform is organised into five principal work-streams – a clinical-intelligence engine that supplies doctors with cumulative patient data [21-22]; a doctor-workforce analytics layer that analyses about 20 million records to guide clinical choices [23-24]; disease-prediction and risk-scoring models that identify high-risk groups for cardiac disease, diabetes, hypertension and other chronic illnesses across a 1.4-billion-person population [24-27]; multimodal imaging and signal-synthesis AI that extracts and synthesises body signals into causal interpretations for clinicians [27-29]; and an acute-care augmented pathway that connects roughly 2 000 critical-care beds to an early-warning system predicting sepsis 24-48 hours before onset, with potential scaling to 100 000 ICU beds [30-33]. A sixth capability, throughput optimisation, sits on top of these work-streams to automate billing, eliminate patient waiting times and auto-populate records, freeing clinicians to focus on patient interaction [34-37].
Collectively, these capabilities have attracted regulatory endorsement: 19 solutions have secured MDSAP approval and nine have received FDA clearance, reflecting a commitment to rigorous validation [38]. He added that Apollo is actively seeking partnerships to co-create new solutions, noting that “a thousand flowers can bloom” when the ecosystem collaborates [39].
Recognising the ethical challenges of AI, the speaker introduced the EASE framework (Ethical, Adoption, Suitability, Explainability). The framework mandates that every algorithm be ethically vetted, appropriately adopted for its clinical context, and fully explainable to health-care workers, ensuring trust and transparency [45-48][S53][S54].
Preventive-care tools include an AI-embedded ultrasound that detects non-alcoholic fatty liver disease (affecting ~40 % of Indian adults) [47-50], a risk-scoring system that personalises lifestyle advice [51-57], and an AI-driven pre-diabetes predictor already validated on 450 k users and poised to reach the nation’s 85 million diabetics [58-62]. In radiology, collaborations with Google have produced AI models that identify tuberculosis on chest X-rays and detect acute brain bleeds, enabling rapid emergency diagnosis [63-66].
To reduce clinician burden, the clinician co-pilot synthesises patient records and saves between one and one-and-a-half hours of doctor time each day [72-74]. A parallel nurse pilot and the integrated care console connect ICU, home and ward monitoring, extending early-warning capabilities beyond the hospital, decreasing staff burnout and saving millions of lives [75-77].
The speaker stressed that these innovations are not confined to metropolitan hospitals. He also highlighted that Apollo’s network now spans more than 1,100 towns and cities across India, reaching patients beyond the major metropolitan areas [85-86]. Mobile vans now deliver non-communicable-disease and cancer screening, tele-ophthalmology services reach remote villages, and data are shared with ASHA workers and district health authorities to accelerate diagnosis in low-resource settings [79-82]. He noted that Apollo is among the largest validators of AI solutions in India, a crucial step for moving pilots into mainstream practice [83-84].
Looking ahead, the vision expands from a “hospital of the future” to a “health-system of the future” that interlinks public and private providers, primary and advanced care, research institutions, universities and health-tech startups. This interconnected “flywheel” will continuously feed data into new predictive, preventive, personalised, participatory and place-agnostic algorithms, driving both health outcomes and economic productivity [90-94][95-98]. He concluded by urging all stakeholders to close skill and regulatory gaps, collaborate across sectors, and make high-quality, place-agnostic care accessible to every community [95-98].
India and that your health care should not be defined by the zip code in which you’re born. It’s about sustainable costs and it’s about preventive care and early detection. It’s a new paradigm in collaborative care where I believe India has an advantage. This advantage is because we not only have one of the highest out -of -pocket payment and therefore we’re creating innovation and keeping our costs low, but also we’re growing more doctors, we’re training more nurses, and we have the largest talent pool of over 600 ,000 AI engineers. All this coming together to create something truly significant. But I’m not here to talk to you about technology. I’m here to share our story. And this story is about using the passion and the mission of bringing health care within the reach of people and using every tool possible to enable this to happen.
Dr. Pratap Siredi. I’m the art chairman and I’m honored to say my father. brought to polar hospitals when he returned from the U .S. almost 43 years ago to bring this, to bring healthcare within the reach of people. Today, we’ve tried to embed and imbibe every technology, whether it’s surgical robots, the proton therapy, all kinds of treatment and curative capability. We’ve gone beyond to say we must find a way to not just use these machines, but also to connect with our customer. So Apollo 24 -7, our digital front door, is actually, not only can you buy your medicines, order your diagnostics, store your health record, but also on Apollo Assist, ask queries, questions, get these answered, and then find ways.
And our market has rewarded us with the volumes that we see. Over 45 million users have come into this. and now we have close to a million users on a daily basis coming in to interact on this ecosystem. These records, these capabilities are getting enhanced every day because of the power of the communications that we have. But moving on, I think what is most important is that we’re not just in the big cities. We’re serving multiple PIN codes across the country and over 1 ,100 towns and cities. Moving across divine methodologies, I just wanted to share with you quickly a few of the things that we’re doing in AI because this is the AI summit. And approximately now we have about 3 .5 million API calls on our AI platforms.
These platforms we’ve divided into five areas. Number one is really our clinical intelligence engine so that a new doctor can have the knowledge and the capability of the cumulative data that we’re providing to the patient. And number two is the cumulative doctor workforce of about 20 million records analyzed. So this is our clinical decision support and our clinical intelligence engine. The next one is the disease prediction and the risk score, because we need to know in a population of 1 .4 billion people, where do we focus? What should we do more? So this is the second work stream, and this goes across cardiac, diabetes, multiple others, including hypertension, but we’re also looking at embedded AI. The next and another critical one is taking images and signals, because the body is an amazing piece of machinery that continues to give us this messaging.
How do we pick this up, synthesize it smarter than any one individual can do, and bring this multimodal signaling into a causal interpretation to thereby enable the doctor. We also have acute care augmented pathways. About 2 ,000 of our critical care beds are connected with our early warning symptom, and there we are predicting. The onset of sepsis. 24 to 48 hours before it happens. Imagine if we could take this AI algorithm and put it into a hundred thousand ICU beds. Imagine the number of lives saved. So here I’m sharing these examples because I believe that the power of AI is directly proportionate to the impact that we can have on lives saved, disease prevented, cost reduction, and therefore talking about cost reduction, the final one is really throughput optimization.
How can you be smarter about billing? How can you ensure that your patient has zero waiting time, that the data capture is using ambient systems, therefore the doctor is able to look at the patient and talk to the patient and you’re doing auto -population of your records. Millions of these capabilities are coming together. We’ve collated them. We’re getting MDSAP approval on almost 19 of them, FDA approval for nine, and we’re looking for partnership to build because I believe in this space. a thousand flowers can bloom, and that there is deeper work to be done on the use of our blood bank and our biobank with genetic testing to move further into disease prediction, biomarkers. So these are just new dimensions opening up.
And I’m sharing more of the examples of how we’re working in these areas, but before I go into those, I want to talk about the EASE framework. I’m happy that our EASE framework has been published fairly extensively because it talks about the ethical considerations of the use of AI. It looks at adoption, the suitability of a certain algorithm within the area that it’s being used, and finally the explainability so that every healthcare worker is able to understand what they use in which environment and what the interpretation means. I believe this is a base framework that we need to put into every healthcare environment. Moving on is another area of deep passion, and that is that while we’re doing the highest end of surgeries, curative care, transplants, etc.
How much can we spend our time on health care prevention? Because for every life -saving intervention, for every 1 ,000 people screened, you will have 11 people where you have averted a major crisis. And therefore, the ability to look at proactive preventive care and get a lot more intuitive on the mechanism of biomarkers and early detection in cancer. We are working with the ultrasound company to do an embedded AI into the ultrasound machine so that we can pick up NAFLD, non -alcoholic fatty liver, of which 40 % of the adult population of India is susceptible to. And if you can pick it up early, you can completely prevent a major crisis if you find it late. These are candidates for liver transplant, a lot of pain and suffering, and some of them potential death.
So the interventions at the appropriate time using technology open up an entire… realm of what we can do differently in this world. I’m sharing now this aspect of how lifestyle changes risk reduction. All of you on Instagram are getting thousands of messages a day on what to eat, how to exercise, what to do better. But is it quantified? Is there a risk scoring? Do you understand the difference between a high -risk group and what they need to do to a low -risk group? But every single group, by understanding the risk profiling and the modifiable risk factors of these non -communicable disease can move into a healthy pattern. This has been studied in partnership with Solventum, the company with 3M, with definitive proof on the power of doing something like this.
We also have a significant product on AI prediabetes which I think we’ve used for a long time. We’ve used it for a long time. We’ve used it for a long time. We’ve used this algorithm over 450 ,000 people. But I would love to see the 85 million diabetics in our country using this to predict and to handle their diabetes better. I also want to move on to the fact that in radiology, because of the years of data and the teleradiology services that we do across the world, we are able to take these images, and here we’ve worked with Google on prediction of tuberculosis in a simple x -ray. We’re working with various other companies, whether it’s an early detection of a brain bleed.
So once somebody goes into the emergency room, you’re quickly able to diagnose these. Each one of these are amazing new factors which are coming in. This is a quick example of the clinician co -pilot. Because I’m running out of time, I’m not going to share this video, but basically… Okay, they are playing the video. Can we have some volume on this? Or I’ll click through, because we’re really running out of time. But basically what the clinician co -pilot does is it’s synthesizing the record so that you’re summarizing. We’re approximately saving… We’re saving one to one and a half hours per day of doctor time in the records. We’re now doing the nurse pilot. I’m moving now to reimagining the way patients are monitored, whether it’s the challenge of a misdiagnosis, the integrated solution, which is looking at Care Console, and the technology stack around this, which is connecting the command station with the ICUs, with home, and with connected wards.
And because of this, we’ve not only saved millions of lives, we’ve saved time for doctors, and this is connected even to external nursing homes in small rural areas. I believe this is a powerful solution where the current AI algorithm has multiple factors from antibiotic usage to early warning symptoms of sepsis, but there are potentially another hundred algorithms that we could add on to this to enhance the quality of decision -making. And share this further, enabling a safer patient care and also less burnout in our staff. I’ve been sharing lots of hospital -based examples, but I do want to say that many of the solutions are applicable in rural India. We’re running mobile vans, we’re doing non -communicable disease screening in small rural environments, we’re finding ways to do cancer screening, tele -ophthalmology screening, and sharing this data and enabling either the ASHA worker or the district health authorities or even the government hospitals to diagnose faster, better, cheaper, and earlier.
And this is really the power of what can be done through early screening. I also do want to say, because for those who are listening from research organizations, from pharmaceuticals, from manufacturing, that we are among the people doing the largest number of validations. So innovation happens from multiple quarters, but validation is what moves a pilot into a mainstream activity. And that is what is critical for our country because you’ve been hearing this over the last two days about the number of pilots happening, but we’re not finding ways to continue this. I believe the hospital of the future is interconnected in multiple ways, from the theatres to the ICUs to using drone delivery. But then as we were drawing and designing this, we actually said, no, our thinking is too small and narrow.
We need to think bigger because the world is more connected. And primary care, preventive care, out there in the market, home care, these are the important redefinition factors of the future of healthcare. And so now I talk not about hospitals of the future, but about health systems of the future. This is what we need to redefine, and we have to do this together. These health systems of the future connect public and private, connect primary care with advanced care, connect research institutions, universities, innovators, health tech startups, all together to build new solutions for the betterment of healthcare. And I believe that this is a flywheel which will drive not just positive health productivity and the economics of the healthcare environment, but this data will enhance into new algorithms.
And these algorithms can be predictive and preventive, and if you find disease earlier, you’re actually saving so many aspects. So let us remove skill gaps. Let us push through regulatory gaps. Let us bring companies, organizations, and people together to build a new healthcare world, which is predictive, preventive, personalized, participatory, and place agnostic. Let every village in any part of the world, or every city, or every apartment building, wherever you are, be able to access good clinical care. Let’s come together to build a healthier world. And definitely, let’s say that this is the time for us to… to dream of finding cures for cancer, of enabling the world to be healthier, and finding a methodology for us to say that we brought our next generation into a healthier world.
Thank you so much, and namaste. Thank you. Thank you.
And our market has rewarded us with the volumes that we see. Over 45 million users have come into this. and now we have close to a million users on a daily basis coming in to interact on this ecosyste…
EventAddressing healthcare inequity requires collaboration and the appropriate use of technology. Inequities exist not only among patients but also among countries, states, and healthcare organisations. Th…
EventRuth Porat highlights how AI is currently enhancing healthcare by enabling early disease detection and making high-quality diagnostics more widely available. She argues that this is helping to democra…
EventAnd our market has rewarded us with the volumes that we see. Over 45 million users have come into this. and now we have close to a million users on a daily basis coming in to interact on this ecosyste…
Event_reportingA team of researchers at Mount Sinai Hospital in New Yorkhas successfullycalibrated an AI tool to more accurately assess the likelihood of hypertrophic cardiomyopathy (HCM) in patients. By assigning s…
UpdatesDevelopment | Infrastructure Roy Jakobs argues that AI provides clinicians with fast and accurate data to support daily work, improving diagnostic capabilities and clinical interventions. This augmen…
EventThe ethics framework includes elements of transparency, accountability, and explainability
EventDr Zhang Xiao: Thank you everyone. I’m glad to be involved in this interesting discussion and I have three points to share after listening to all the distinguished speakers. The first is why we are st…
EventChris Martin: Thanks, Ahmed. Well, everyone, I’ll walk through I think a little bit of this presentation here on what DCO’s view is on ethical AI governance. And then my colleague, Matt Sharp, w…
EventBoth industry and humanitarian perspectives converged on integrating governance considerations throughout the entire AI system lifecycle. This approach prevents governance from becoming mere complianc…
Event“Community health workers carry portable x -ray devices directly to people’s homes.”<a href=”https://dig.watch/event/india-ai-impact-summit-2026/keynote-by-sangita-reddy-joint-managing-director-apollo…
EventThe discussion maintained a cautiously optimistic and collaborative tone throughout. It began with enthusiasm about AI’s potential in healthcare but was tempered by acknowledgment of serious challenge…
Event“The AI platform has handled roughly 3.5 million API calls.”
The speaker’s figure matches the internal statement that the platform has about 3.5 million API calls on its AI platforms [S6].
“India enjoys a unique strategic advantage: a large out‑of‑pocket spending base that drives innovation while keeping prices low, a rapidly expanding cadre of doctors and nurses, and a talent pool of more than 600 000 AI engineers.”
Several sources note that India’s high out-of-pocket health spending is framed as a catalyst for innovation and that the country is positioned as a strategic AI hub with cost-competitive innovation and a large talent pool, but they do not provide the specific figure of 600 000 AI engineers or detailed data on doctor/nurse expansion [S4] and [S62] and [S63] and [S64].
“The AI platform is organised into five principal work‑streams – a clinical‑intelligence engine, a doctor‑workforce analytics layer, disease‑prediction and risk‑scoring models, multimodal imaging and signal‑synthesis AI, and an acute‑care augmented pathway.”
The description of five AI work-streams, including a clinical-intelligence engine, aligns with the speaker’s outline of the platform’s structure, as the internal briefing also mentions five areas and a clinical intelligence engine, though it does not detail the specific analytics or prediction layers cited in the report [S6].
Speaker 1 consistently emphasizes an AI‑centric, equitable, and preventive health‑care model that combines digital platforms, large‑scale AI services, ethical governance, and integrated system design, while calling for capacity‑building and regulatory reforms.
High internal consensus – the speaker’s multiple arguments reinforce a unified vision of AI‑enabled, inclusive health care, suggesting strong alignment among the presented points and indicating that future policy and investment discussions can build on this cohesive narrative.
The transcript contains only statements from Speaker 1, and the supplied list of arguments all originates from the same speaker. Consequently, there are no opposing viewpoints, no partial agreements, and no unexpected areas of disagreement identified in the material provided.
None – the discussion reflects a single perspective, indicating full consensus (or lack of debate) on the topics addressed.
The discussion was driven by a single, highly articulate speaker whose comments repeatedly reframed the conversation—from a focus on cutting‑edge AI technologies to the larger goals of equity, prevention, ethical governance, and systemic integration. Each pivotal remark introduced a new dimension (e.g., digital front‑door adoption, structured AI work streams, sepsis early‑warning, the EASE ethical framework, preventive screening, workflow efficiency, and ecosystem‑level vision) that redirected audience attention, deepened analysis, and built momentum toward a holistic vision of a future health system. Collectively, these thought‑provoking statements shaped the dialogue into a coherent narrative that linked technical possibility with societal need, ultimately urging collaborative, cross‑sector effort to realize a predictive, preventive, and inclusive health‑care future.
Disclaimer: This is not an official session record. DiploAI generates these resources from audiovisual recordings, and they are presented as-is, including potential errors. Due to logistical challenges, such as discrepancies in audio/video or transcripts, names may be misspelled. We strive for accuracy to the best of our ability.
Related event

